Tiline Pharma

Edegem ·KBO/BCE: BE 0794.425.941

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	26-06-2025	35 d early	2025-00181044
31-12-2023	31-07-2024	26-08-2024	26 d late	2024-00367337

Metric	This company	Sector median	Position in the sector
Solvency	58.7%	60.6%	better than 48% of 12463 sector peers
Net result	€25k	€31k	better than 45% of 12465 sector peers
Equity	€32k	€63k	better than 32% of 12471 sector peers
Gross operating margin	€35k	€52k	better than 38% of 12451 sector peers
Total assets	€55k	€124k	better than 22% of 12464 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€55k
Current assets	29/58	€55k
Cash & bank	54/58	€55k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€55k
Equity	10/15	€32k
Contributions / capital	10/11	€5k
Reserves	13	€27k
Amounts payable	17/49	€23k
Amounts payable within one year	42/48	€22k
Trade debts payable within one year	44	€699
Income statement
Gross operating margin	9900	€35k
Operating result	9901	€35k
Financial charges	65	€128
Result before taxes	9903	€35k
Income taxes	67/77	€10k
Net result for the period	9904	€25k
Result to be appropriated	9905	€25k

Summary